Researchers have discovered that the Covid-19 virus can trigger the immune system to attack cancer cells. The virus's RNA ...

Waltham, Massachusetts Friday, November 15, 2024, 15:00 Hrs [IST] ...

Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

High-dose LTI-03 (5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both ...

Aileron Therapeutics (ALRN) announced positive topline data from Cohort 2 of its Phase 1b clinical trial evaluating the safety and tolerability ...

50 – 80 years of age Have a 20 pack-year history of smoking (1 pack a day for 20 years or 2 packs a day for 10 years) Are a current smoker or have quit within the last 15 years If you meet the ...

DelveInsight’s, “Interstitial Lung Diseases Pipeline Insight 2024” report provides comprehensive insights about 120+ ...

Idiopathic pulmonary fibrosis is a chronic, progressive, incurable lung disease, leading to irreversible lung tissue ...

and lung diseases. Yet fibrosis of these organs remains a deadly disease with limited treatments. "The crosstalk between the immune system and fibroblasts is even more complex than we expected ...

Slowing or stopping fibrosis can help treat heart, liver, kidney, and lung diseases ... out exactly how immune cells trigger scar-forming fibroblasts to become activated and cause fibrosis ...